Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01746797 · ClinicalTrials.gov registry record
Symptom Tracking in Assisted Reproductive Technologies
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 49
- Enrollment target
NCT01746797: Completed study, sponsored by Massachusetts General Hospital.
NCT01746797 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01746797 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
This study assesses risk factors for depressive relapse in women undergoing fertility treatment with histories of major depressive disorder (MDD) or bipolar disorder. The study is focused on the acute risk factors of depressive relapse. The investigators hypothesize that risk for depressive relapse will be greater among women who stop antidepressants compared to those who continue treatment with these agents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-01-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01746797
The ClinicalTrials.gov registry entry for NCT01746797 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01746797 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01746797 about?
NCT01746797 is a clinical study titled "Symptom Tracking in Assisted Reproductive Technologies". This study assesses risk factors for depressive relapse in women undergoing fertility treatment with histories of major depressive disorder (MDD) or bipolar disorder. The study is focused on the acute risk factors of depressive relapse. The investigators hypothesize that risk for depressive relapse...
What is the current status of trial NCT01746797?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2012-10. Estimated completion is 2018-01-16.
Who is sponsoring clinical trial NCT01746797?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.